Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (30895)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 28, 2015 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: What’s the future holding for us? World J Gastroenterol 2015; 21(44): 12558-12575 [PMID: 26640332 DOI: 10.3748/wjg.v21.i44.12558] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i44/12558.htm |
| Number | Citing Articles |
| 1 |
Shaghayegh Gorji, Ahmad Fakharian, Rezvan Abbasi. Passive observer-based controller design for a class of Lipschitz nonlinear time-varying systems with application to Hepatitis B disease. Proceedings of the Institution of Mechanical Engineers, Part I: Journal of Systems and Control Engineering 2024; doi: 10.1177/09596518241236925
|
| 2 |
Aina-Cathrine Øvergård, Lars Are Hamre, Heidi Kongshaug, Frank Nilsen. RNAi-mediated treatment of two vertically transmitted rhabdovirus infecting the salmon louse (Lepeophtheirus salmonis). Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14282-3
|
| 3 |
James Fung, Ching-Lung Lai, Wai-Kay Seto, Man-Fung Yuen. Emerging drugs for the treatment of hepatitis B. Expert Opinion on Emerging Drugs 2016; 21(2): 183 doi: 10.1517/14728214.2016.1162155
|
| 4 |
Jung-Ah Kang, Songwon Kim, Minji Park, Hyun-Jin Park, Jeong-Hyun Kim, Sanghyeok Park, Jeong-Ryul Hwang, Yong-Chul Kim, Yoon Jun Kim, Yuri Cho, Mi Sun Jin, Sung-Gyoo Park. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-10200-5
|
| 5 |
Sebastien Boucle, Leda Bassit, Maryam Ehteshami, Raymond F. Schinazi. Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities. Clinics in Liver Disease 2016; 20(4): 737 doi: 10.1016/j.cld.2016.07.001
|
| 6 |
Xiaojun Sun, Chengwei Wang, Bian Wang, Xiuzhen Yang, Hongtao Xu, Meilong Shen, Kuichun Zhu, Susan Cu-Uvin. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group. Infectious Diseases in Obstetrics and Gynecology 2020; 2020: 1 doi: 10.1155/2020/4305950
|
| 7 |
Yin Zhang, Yanming Xie, Yiying Zhang, Yan Liu, Yan Zhuang. Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tablets. Biomedical Reports 2016; 5(5): 595 doi: 10.3892/br.2016.765
|
| 8 |
Young Li, Yang Wu, Xiaohu Zheng, Jingjing Cong, Yanyan Liu, Jiabin Li, Rui Sun, Zhigang G. Tian, Haiming M. Wei. Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine Secretion. Frontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00569
|
| 9 |
Haiyong Jia, Yang Song, Ji Yu, Peng Zhan, Diwakar Rai, Xiaohong Liang, Chunhong Ma, Xinyong Liu. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. European Journal of Medicinal Chemistry 2017; 136: 144 doi: 10.1016/j.ejmech.2017.04.048
|
| 10 |
Lixia Gao, Jie Yang, Jutao Feng, Ziying Liu, Ying Dong, Jiangyan Luo, Liangzhentian Yu, Jiamei Wang, Hongying Fan, Weifeng Ma, Tiancai Liu. PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.856463
|
| 11 |
Jing Tu, Jiao Jiao Li, Zhi Jie Shan, Hong Lin Zhai. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics. Antiviral Research 2017; 137: 151 doi: 10.1016/j.antiviral.2016.11.026
|
| 12 |
Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai. Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Advanced Drug Delivery Reviews 2020; : 64 doi: 10.1016/j.addr.2020.07.022
|
| 13 |
MERYEM GUVENIR, AYSE ARIKAN. Hepatitis B Virus: From Diagnosis to Treatment. Polish Journal of Microbiology 2020; 69(4): 391 doi: 10.33073/pjm-2020-044
|
| 14 |
Jingying Qiu, Qineng Gong, Jian Gao, Wang Chen, Yinpeng Zhang, Xiaoke Gu, Daoquan Tang. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. European Journal of Medicinal Chemistry 2018; 144: 424 doi: 10.1016/j.ejmech.2017.12.042
|
| 15 |
Soo-Hyun Park, Kyung-Seok Park, Nam-Hee Kim, Joong-Yang Cho, Moon Soo Koh, Jin Ho Lee. Clevudine Induced Mitochondrial Myopathy. Journal of Korean Medical Science 2017; 32(11): 1857 doi: 10.3346/jkms.2017.32.11.1857
|
| 16 |
Dongki Yang. Application of Nanotechnology in the COVID-19 Pandemic. International Journal of Nanomedicine 2021; : 623 doi: 10.2147/IJN.S296383
|
| 17 |
Lavanya Singh, Hendrik G. Kruger, Glenn E.M. Maguire, Thavendran Govender, Raveen Parboosing. The role of nanotechnology in the treatment of viral infections. Therapeutic Advances in Infectious Disease 2017; 4(4): 105 doi: 10.1177/2049936117713593
|
| 18 |
Shaghayegh Gorji, Ahmad Fakharian, Rezvan Abbasi. Virtually Euler–Lagrange form for feedback passivation of a wide range of non-Euler–Lagrange systems: Adaptive passivity-based control of hepatitis B disease. Proceedings of the Institution of Mechanical Engineers, Part I: Journal of Systems and Control Engineering 2023; 237(7): 1313 doi: 10.1177/09596518221146928
|
| 19 |
Jonathan Forde, Stanca Ciupe, Ariel Cintron-Arias, Suzanne Lenhart. Optimal Control of Drug Therapy in a Hepatitis B Model. Applied Sciences 2016; 6(8): 219 doi: 10.3390/app6080219
|
| 20 |
Yudha Gusti Wibowo, Bimastyaji Surya Ramadan, Tarmizi Taher, Khairurrijal Khairurrijal. Advancements of Nanotechnology and Nanomaterials in Environmental and Human Protection for Combatting the COVID-19 During and Post-pandemic Era: A Comprehensive Scientific Review. Biomedical Materials & Devices 2024; 2(1): 34 doi: 10.1007/s44174-023-00086-9
|
| 21 |
Wu Guicheng, An Xuan, Xiang Yi, Wei Fang, Xia Lina, Zhong Qing, Du Biao, Liu Yong. Effect of Cytotoxic T Lymphocytes Induced by Recombinant Adeno-Associated Virus on Different Hepatitis B Virus Genes. Hepatitis Monthly 2016; 17(5) doi: 10.5812/hepatmon.42685
|
| 22 |
Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu. 2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants. Medicinal Research Reviews 2018; 38(3): 977 doi: 10.1002/med.21490
|
| 23 |
Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, Vikas Sharma, Gaber El-Saber Batiha, Harpreet Kaur, Jashanpreet Singh, Deepak Kumar, Neha Sharma, Ajeet Kaushik, Raj Kumar. Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications. Pharmaceutics 2023; 15(2): 451 doi: 10.3390/pharmaceutics15020451
|
| 24 |
Yongning Xin, Wei Li, Linlin Lu, Li Zhou, David W. Victor, Shiying Xuan. Antiviral effects of Stichopus japonicus acid mucopolysaccharide on hepatitis B virus transgenic mice. Journal of Ocean University of China 2016; 15(4): 719 doi: 10.1007/s11802-016-3124-4
|
| 25 |
Hyun Jung Jo, Gyu Nam Park, Hye Ran Kim, Min Ju Kim, Kyung A Shin, Seung Bok Hong, Kyung Soo Chang. Differences in Hematological Characteristics, Including Cholesterol and Apolipoprotein B and E, between Hepatitis B Virus and Hepatitis C Virus Patients in Korea. Journal of Bacteriology and Virology 2016; 46(3): 152 doi: 10.4167/jbv.2016.46.3.152
|
| 26 |
Sana Mansha, Muhammad Imran, Amir Miraj Ul Hussain Shah, Muhsin Jamal, Fayyaz Ahmed, Muhammad Atif, Muhammmad Saleem, Sher Zaman Safi, Zareen Fatima, Ahmed Bilal Waqar. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan. Viral Immunology 2017; 30(5): 366 doi: 10.1089/vim.2016.0144
|
| 27 |
Ting Yuan, Yongfang Jiang, Mei Li, Wei Li. Chronic hepatitis B surface antigen seroclearance‐related immune factors. Hepatology Research 2017; 47(1): 49 doi: 10.1111/hepr.12726
|
| 28 |
Shrihari A. Anikhindi, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Ideal Cure for Hepatitis B Infection: The Target is in Sight. Journal of Clinical and Experimental Hepatology 2018; 8(2): 188 doi: 10.1016/j.jceh.2017.10.002
|
| 29 |
涛 巫. Immunotherapy for Chronic Hepatitis B Virus Infection. Pharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
|
| 30 |
Naoki Takizawa, Manabu Yamasaki. Current landscape and future prospects of antiviral drugs derived from microbial products. The Journal of Antibiotics 2018; 71(1): 45 doi: 10.1038/ja.2017.115
|
| 31 |
Claire Pierra Rouviere, Cyril B. Dousson, John E. Tavis. HBV replication inhibitors. Antiviral Research 2020; 179: 104815 doi: 10.1016/j.antiviral.2020.104815
|
| 32 |
Yunwen Wang, Shendan Wang, Xuefen Tao, Yuan Wang, Yuxuan Wu, Na Chen, Chenxian Hu, Hao Wang, Shuang Yu, Rong Sheng. The SAR-based development of small molecular HBV capsid assembly modulators. Medicinal Chemistry Research 2022; 31(9): 1414 doi: 10.1007/s00044-022-02936-5
|
| 33 |
Akriti Rai, Kamal Shah, Rajiv Sharma, Hitesh Kumar Dewangan. A Comprehensive Review on COVID-19: Emphasis on Current Vaccination
and Nanotechnology Aspects. Recent Patents on Nanotechnology 2023; 17(4): 359 doi: 10.2174/1872210516666220819104853
|
| 34 |
Andrea Carracedo Rodriguez, Matthias Chung, Stanca Ciupe. Understanding the Complex Patterns Observed during Hepatitis B Virus Therapy. Viruses 2017; 9(5): 117 doi: 10.3390/v9050117
|